55478 Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices 

decision to designate a class of 

employees at the Ames laboratory, in 

Ames, Iowa, as an addition to the 

Special Exposure Cohort (SEC) under 

the Energy Employees Occupational 

Illness Compensation Program Act of 

2000. On August 8, 2006, as provided 

for under 42 U.S.C. 7384q(b), the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

Department of Energy (DOE) employees or 

DOE contractor of subcontractor employees 

who worked at the Ames Laboratory in one 

or more of the following facilities/locations: 

Chemistry Annex 1 (also known as ‘‘the old 

women’s gymnasium’’ and ‘‘Little Ankeny’’), 

Chemistry Annex 2, chemistry Building (also 

known as ‘‘Gilman Hall’’), Research Building, 

or the Metallurgical Building (also known as 

‘‘Harley Wilhelm Hall’’) from January 1, 1942 

through December 31, 1954 for a number of 

work days aggregating at least 250 work days, 

or in combination with work days within the 

parameters (excluding aggregate work day 

requirements) established for one or more 

classes of employees in the SEC, and who 

were monitored or should have been 

monitored. 

This designation became effective on 

September 7, 2006, as provided for 

under 42 U.S.C. 7384l(14)(C). Hence, 

beginning on September 7, 2006, 

members of this class of employees, 

defined as reported in this notice, 

became members of the Special 

Exposure Cohort. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can also be submitted by e-mail 

to OCAS@CDC.GOV. 

Dated: September 18, 2006. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 06–7975 Filed 9–21–06; 8:45 am] 

BILLING CODE 4163–19–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Institute for Occupational 

Safety and Health, Safety and 

Occupational Health Study Section 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following committee 

meeting. 

Name: Safety and Occupational Health 

Study Section (SOHSS), National Institute for 

Occupational Safety and Health (NIOSH). 

Times and Dates: 

8 a.m.–8:30 a.m., October 10, 2006 (Open). 

8:30 a.m.–5 p.m., October 10, 2006 

(Closed). 

8:30 a.m.–5 p.m., October 11, 2006 

(Closed). 

Place: Embassy Suites Hotel, 1900 

Diagonal Road, Alexandria, Virginia 22314, 

telephone 703.684.5900, fax 703.684.1403. 

Purpose: The Safety and Occupational 

Health Study Section will review, discuss, 

and evaluate grant application(s) received in 

response to the Institute’s standard grants 

review and funding cycles pertaining to 

research issues in occupational safety and 

health, and allied areas. 

It is the intent of NIOSH to support broadbased research endeavors in keeping with the 

Institute’s program goals. This will lead to 

improved understanding and appreciation for 

the magnitude of the aggregate health burden 

associated with occupational injuries and 

illnesses, as well as to support more focused 

research projects, which will lead to 

improvements in the delivery of occupational 

safety and health services, and the 

prevention of work-related injury and illness. 

It is anticipated that research funded will 

promote these program goals. 

Matters to be Discussed: The meeting will 

convene in open session from 8–8:30 a.m. on 

October 10, 2006, to address matters related 

to the conduct of Study Section business. 

The remainder of the meeting will proceed in 

closed session. The purpose of the closed 

session is for the study section to consider 

safety and occupational health-related grant 

applications. These portions of the meeting 

will be closed to the public in accordance 

with provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, Management 

Analysis and Services Office, CDC, pursuant 

to Section 10(d) Pub. L. 92–463. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: Price 

Connor, PhD, NIOSH Health Scientist, 1600 

Clifton Road, NE., Mailstop E–20, Atlanta, 

Georgia 30333, telephone 404.498.2511, fax 

404.498.2569. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 18, 2006. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 06–8050 Filed 9–21–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10182, CMS–

10194, CMS–R–136 and CMS–10185] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Model 

Creditable Coverage Disclosure Notices; 

Use: Section 1860D—1 of the MMA 

requires entities that offer prescription 

drug benefits under any of the types of 

coverage described in 42 CFR 423.56(b) 

to provide a disclosure of creditable 

coverage status to all Medicare Part D 

eligible individuals covered under the 

entity’s plan. These disclosure notices 

must be provided to Part D eligible 

individuals, at a minimum, at the 

following times: (1) Prior to an 

individual’s initial enrollment period 

for Part D, (2) prior to the effective date 

of enrollment in the entity’s coverage, 

and upon any change in creditable 

status; (3) prior to the commencement of 

the Part D Annual Coordinated Election 

Period (ACEP) which begins on 

November 15 of each year, and (4) upon 

request by the individual. Disclosure of 

whether prescription drug coverage is 

creditable provides Medicare eligible 

individuals with important information 

relating to their Medicare Part D 

enrollment. Form Number: CMS–10182 

(OMB#: 0938–0990); Frequency: 


sroberts on PROD1PC70 with NOTICES